SynthesisInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021
High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
Synthesis in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021Pooled it
- Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru.Global epidemiology · 2024Article
- High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.Influenza and other respiratory viruses · 2024Article
- Article
- Population-Level Immunity for Transient Suppression of COVID-19 Waves in Japan from April 2021 to September 2022.Vaccines · 2023Article
- SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave.PLoS neglected tropical diseases · 2023Article
- Safety of International Professional Sports Competitions During the COVID-19 Pandemic: The Association Football Experience.Sports medicine (Auckland, N.Z.) · 2023Article
- Article
- Achieving herd immunity in South America.Global health research and policy · 2023Article
- COVID-19 in Latin America: A Snapshot in Time and the Road Ahead.Infectious diseases and therapy · 2023Review
- Severe acute respiratory syndrome coronavirus 2 seroprevalence among patients with pulmonary tuberculosis.Revista da Associacao Medica Brasileira (1992) · 2023Article
- Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America.IJID regions · 2022Article
- [Social determinants associated with self-reporting of symptoms and access to COVID-19 testing and diagnosis in the Plurinational State of BoliviaDeterminantes sociais associados ao autorrelato de sintomas, acesso a testagem e diagnóstico de COVID-19 no Estado Plurinacional da Bolívia].Revista panamericana de salud publica = Pan American journal of public health · 2022Article
- Article
- Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
- Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.PLoS neglected tropical diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herd immunity is considered to be a relevant aspect of COVID-19 epidemiology. In this regard, seroprevalence studies are essential for understanding how far countries and regions are from that potential point. This study analyzed seroprevalence data in nine studies from South America, which is a region that has been badly affected by COVID-19. Seroprevalence values were high, with percentages up to 70.0% (95% CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data enabled a pooled seroprevalence to be obtained, estimated at 33.6% (95% CI 28.6-38.5%). Despite this, the COVID-19 pandemic in South America continues to significantly affect countries such as Brazil, Colombia, and Peru.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.